#BatCure - Twitter Hashtag

almost 5 years ago

Congrats Chiara Soldati from the @Tigem_Telethon Medina group @HCS_Tigem for her @EmboMolMed publication. Their work focused on cellular and murine models of #BattenDisease and discovered increased levels of globotriaosylceramide in models of CLN3 and CLN7 diseases #Batcure (1/2)

Tigem_Telethon's tweet photo. Congrats Chiara Soldati from the @Tigem_Telethon Medina group @HCS_Tigem for her @EmboMolMed publication. Their work focused on cellular and murine models of #BattenDisease and discovered increased levels of globotriaosylceramide in models of CLN3 and CLN7 diseases #Batcure (1/2) https://t.co/uDmoG96C4r

1

11

2

0

Irene LoFa @lofa_irene

almost 5 years ago

Happy to be part of this amazing story and consortium. #BattenDisease #BatCure

IBFG @ibfg_es

almost 5 years ago

#IBFG_Paper by Dr. @bolanosjuanp Lab (@usal & @IBSAL_IIS) in collaboration with Dr. Medina Lab (@Tigem_Telethon) in @EmboMolMed, on the beneficial effect of tamoxifen in two models of @BattenDisease. A joint work funded by the EU H2020 @BAT_Cure consortium.

ibfg_es's tweet photo. #IBFG_Paper by Dr. @bolanosjuanp Lab (@usal & @IBSAL_IIS) in collaboration with Dr. Medina Lab (@Tigem_Telethon) in @EmboMolMed, on the beneficial effect of tamoxifen in two models of @BattenDisease. A joint work funded by the EU H2020 @BAT_Cure consortium. https://t.co/tbwIk1NRzq

1

29

9

0

1

6

2

0

HCS facility at TIGEM @HCS_Tigem

almost 5 years ago

Proud to share our work “ Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype” published today in #Embo_Molecular_Medicine. Thanks a lot to #Tigem_telethon, #Horizon2020 funding and our great consortium #BatCure. https://t.co/4cilKnbhbC

0

1

0

Horizon Europe 🇪🇺 @HorizonEU

over 8 years ago

Want to know more about #BattenDisease and what the #EU does to tackle it? Discover #H2020 project #BATcure advancing the development of new therapeutic options https://t.co/gQRjjUVyrH #ResearchImpactEU #InvestEUresearch 🇪🇺